Paper41501528
Gut mucosal mycobiome profiling in Crohn's disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum.
Huang Z and 19 others. Nat Metab, 2026. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Gut mucosal mycobiome profiling in Crohn's disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum. Papers, record 41501528. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41501528
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut mucosal mycobiome profiling in Crohn's disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Crohn Disease | Major topic |
| Cladosporium | Major topic |
| Intestinal Mucosa | Major topic |
| Mycobiome | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Female | |
| Male | |
| Adult | |
| Feces |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82172323 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 32100134 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 823B2010 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 32372334 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82304144 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 41530288 | Publisher Correction: Gut mucosal mycobiome profiling in Crohn's disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum. | https://conductscience.org/library/papers/41530288 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29670252 | Urbanization and the gut microbiota in health and inflammatory bowel disease. | Nat Rev Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29670252 | PubMed |
| 2 | 38437854 | Crohn's disease. | Lancet | 2024 | https://conductscience.org/library/papers/38437854 | PubMed |
| 3 | 29141957 | Adherent-invasive Escherichia coli in inflammatory bowel disease. | Gut | 2018 | https://conductscience.org/library/papers/29141957 | PubMed |
| 4 | 31182571 | Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31182571 | PubMed |
| 5 | 33011176 | Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation. | Gastroenterology | 2021 | https://conductscience.org/library/papers/33011176 | PubMed |
| 6 | 36182668 | The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. | Lancet Microbe | 2022 | https://conductscience.org/library/papers/36182668 | PubMed |
| 7 | 35296857 | Immune regulation by fungal strain diversity in inflammatory bowel disease. | Nature | 2022 | https://conductscience.org/library/papers/35296857 | PubMed |
| 8 | 33548172 | Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies. | Cell | 2021 | https://conductscience.org/library/papers/33548172 | PubMed |
| 9 | 33707263 | Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice. | Science | 2021 | https://conductscience.org/library/papers/33707263 | PubMed |
| 10 | 30850233 | Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models. | Cell Host Microbe | 2019 | https://conductscience.org/library/papers/30850233 | PubMed |
| 11 | 29073277 | Isolation, purification and characterization of 5'-phosphodiesterase from Aspergillus fumigatus. | PLoS One | 2017 | https://conductscience.org/library/papers/29073277 | PubMed |
| 12 | 26083617 | Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2015 | https://conductscience.org/library/papers/26083617 | PubMed |
| 13 | 27651359 | Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease. | mBio | 2016 | https://conductscience.org/library/papers/27651359 | PubMed |
| 14 | 26843508 | Fungal microbiota dysbiosis in IBD. | Gut | 2017 | https://conductscience.org/library/papers/26843508 | PubMed |
| 15 | 37683651 | Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/37683651 | PubMed |
| 16 | 27027296 | Candidalysin is a fungal peptide toxin critical for mucosal infection. | Nature | 2016 | https://conductscience.org/library/papers/27027296 | PubMed |
| 17 | 38918447 | The pathobiology of human fungal infections. | Nat Rev Microbiol | 2024 | https://conductscience.org/library/papers/38918447 | PubMed |
| 18 | 30202057 | Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. | Nat Commun | 2018 | https://conductscience.org/library/papers/30202057 | PubMed |
| 19 | 32598884 | Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. | Gastroenterology | 2020 | https://conductscience.org/library/papers/32598884 | PubMed |
| 20 | 34784344 | Multivariable association discovery in population-scale meta-omics studies. | PLoS Comput Biol | 2021 | https://conductscience.org/library/papers/34784344 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42747030 | The gut microbiota as a regulator of intestinal stem-cell fate: bacterial and fungal control of differentiation and regeneration. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42747030 | PubMed |
| 42377935 | Yeasts in the gastrointestinal tract. | FEMS Yeast Res | 2026 | https://conductscience.org/library/papers/42377935 | PubMed |
| 42326871 | Dysfunction of mitochondria in intestinal epithelial cells: a key player in the pathogenesis of inflammatory bowel diseases. | Gastroenterol Rep (Oxf) | 2026 | https://conductscience.org/library/papers/42326871 | PubMed |
| 41928387 | Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease. | Gut Microbes | 2026 | https://conductscience.org/library/papers/41928387 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41501528
GET https://conductscience.org/api/papers/v1/41501528/references?page=2